CHAD M ROBINS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHAD M ROBINS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHAD M ROBINS. CHAD M ROBINS is CEO and Chairman in Adaptive Biotechnologies Corp ($ADPT).
Latest Insider Trading Transactions of CHAD M ROBINS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 36.51 | 4,937 | 180,250 | 1,789,923 | 1.8 M to 1.8 M (-0.28 %) |
Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.63 | 16,680 | 627,668 | 1,778,180 | 1.8 M to 1.8 M (-0.93 %) |
Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 294,720 | |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 294,720 | |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 311,400 | |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 311,400 | |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 20,668 | 6,820 | 328,080 | |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 20,668 | 6,820 | 328,080 | |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.79 | 1,200 | 45,348 | 1,778,180 | 1.8 M to 1.8 M (-0.07 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.79 | 1,200 | 45,348 | 1,778,180 | 1.8 M to 1.8 M (-0.07 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.19 | 15,480 | 575,701 | 1,779,380 | 1.8 M to 1.8 M (-0.86 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.19 | 15,480 | 575,701 | 1,779,380 | 1.8 M to 1.8 M (-0.86 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.96 | 9,884 | 375,197 | 1,778,180 | 1.8 M to 1.8 M (-0.55 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.96 | 9,884 | 375,197 | 1,778,180 | 1.8 M to 1.8 M (-0.55 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.48 | 6,796 | 254,714 | 1,788,064 | 1.8 M to 1.8 M (-0.38 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.48 | 6,796 | 254,714 | 1,788,064 | 1.8 M to 1.8 M (-0.38 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 38.14 | 20,668 | 788,278 | 1,778,180 | 1.8 M to 1.8 M (-1.15 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 38.14 | 20,668 | 788,278 | 1,778,180 | 1.8 M to 1.8 M (-1.15 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 20,668 | 6,820 | 1,798,848 | 1.8 M to 1.8 M (+1.16 %) |
Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 20,668 | 6,820 | 1,798,848 | 1.8 M to 1.8 M (+1.16 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 33,132 | 10,934 | 348,748 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.15 | 13,503 | 623,163 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.65 | 19,629 | 896,064 | 1,791,683 | 1.8 M to 1.8 M (-1.08 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 33,132 | 10,934 | 1,811,312 | 1.8 M to 1.8 M (+1.86 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 33,132 | 10,934 | 348,748 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.15 | 13,503 | 623,163 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.65 | 19,629 | 896,064 | 1,791,683 | 1.8 M to 1.8 M (-1.08 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 33,132 | 10,934 | 1,811,312 | 1.8 M to 1.8 M (+1.86 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 24,560 | 8,105 | 381,880 | |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 406,440 | |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 28,440 | 9,385 | 423,120 | |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.52 | 400 | 18,208 | 1,778,180 | 1.8 M to 1.8 M (-0.02 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.91 | 24,160 | 1,085,026 | 1,778,580 | 1.8 M to 1.8 M (-1.34 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 24,560 | 8,105 | 1,802,740 | 1.8 M to 1.8 M (+1.38 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.41 | 16,680 | 740,759 | 1,778,180 | 1.8 M to 1.8 M (-0.93 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.38 | 28,040 | 1,244,415 | 1,778,180 | 1.8 M to 1.8 M (-1.55 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.76 | 400 | 17,504 | 1,806,220 | 1.8 M to 1.8 M (-0.02 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 28,440 | 9,385 | 1,806,620 | 1.8 M to 1.8 M (+1.60 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 451,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 501,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 551,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Gift | G | 0.00 | 100,000 | 0 | 1,778,180 | 1.9 M to 1.8 M (-5.32 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 40.29 | 50,000 | 2,014,500 | 1,878,180 | 1.9 M to 1.9 M (-2.59 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,928,180 | 1.9 M to 1.9 M (+2.66 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 40.46 | 50,000 | 2,023,000 | 1,878,180 | 1.9 M to 1.9 M (-2.59 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,928,180 | 1.9 M to 1.9 M (+2.66 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 39.95 | 49,100 | 1,961,545 | 1,878,180 | 1.9 M to 1.9 M (-2.55 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 39.31 | 900 | 35,379 | 1,927,280 | 1.9 M to 1.9 M (-0.05 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,928,180 | 1.9 M to 1.9 M (+2.66 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 451,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 501,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 551,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Gift | G | 0.00 | 100,000 | 0 | 1,778,180 | 1.9 M to 1.8 M (-5.32 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 40.29 | 50,000 | 2,014,500 | 1,878,180 | 1.9 M to 1.9 M (-2.59 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,928,180 | 1.9 M to 1.9 M (+2.66 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 40.46 | 50,000 | 2,023,000 | 1,878,180 | 1.9 M to 1.9 M (-2.59 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,928,180 | 1.9 M to 1.9 M (+2.66 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 39.95 | 49,100 | 1,961,545 | 1,878,180 | 1.9 M to 1.9 M (-2.55 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 39.31 | 900 | 35,379 | 1,927,280 | 1.9 M to 1.9 M (-0.05 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,928,180 | 1.9 M to 1.9 M (+2.66 %) |
May 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 45,000 | 14,850 | 601,560 | |
May 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 36.13 | 8,814 | 318,450 | 1,878,180 | 1.9 M to 1.9 M (-0.47 %) |
May 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 35.47 | 36,186 | 1,283,517 | 1,886,994 | 1.9 M to 1.9 M (-1.88 %) |
May 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 45,000 | 14,850 | 1,923,180 | 1.9 M to 1.9 M (+2.40 %) |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 646,560 | |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 33,360 | 11,009 | 657,680 | |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 5,560 | 1,835 | 691,040 | |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 28.34 | 10,620 | 300,971 | 1,878,180 | 1.9 M to 1.9 M (-0.56 %) |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | S | 27.62 | 500 | 13,810 | 1,888,800 | 1.9 M to 1.9 M (+0.03 %) |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 28.20 | 33,360 | 940,752 | 1,878,180 | 1.9 M to 1.9 M (-1.75 %) |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 33,360 | 11,009 | 1,911,540 | 1.9 M to 1.9 M (+1.78 %) |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 26.74 | 3,160 | 84,498 | 1,878,180 | 1.9 M to 1.9 M (-0.17 %) |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 25.62 | 900 | 23,058 | 1,881,340 | 1.9 M to 1.9 M (-0.05 %) |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 24.83 | 1,500 | 37,245 | 1,882,240 | 1.9 M to 1.9 M (-0.08 %) |
Apr 15 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 5,560 | 1,835 | 1,883,740 | 1.9 M to 1.9 M (+0.30 %) |
Mar 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 5,560 | 1,835 | 696,600 | |
Mar 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 702,160 | |
Mar 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 24.38 | 887 | 21,625 | 1,878,180 | 1.9 M to 1.9 M (-0.05 %) |
Mar 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 23.50 | 973 | 22,866 | 1,879,067 | 1.9 M to 1.9 M (-0.05 %) |
Mar 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 22.37 | 3,700 | 82,769 | 1,880,040 | 1.9 M to 1.9 M (-0.20 %) |
Mar 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 5,560 | 1,835 | 1,883,740 | 1.9 M to 1.9 M (+0.30 %) |
Mar 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 22.30 | 11,120 | 247,976 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
Mar 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
Feb 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | A | 31.71 | 300,000 | 9,513,000 | 300,000 | |
Feb 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 713,280 | |
Feb 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 31.56 | 11,120 | 350,947 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
Feb 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 724,000 | |
Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 735,200 | |
Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 31.30 | 11,120 | 348,056 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 31.18 | 11,120 | 346,722 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 746,400 | |
Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 757,600 | |
Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 768,800 | |
Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 30.99 | 11,120 | 344,609 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 31.90 | 800 | 25,520 | 1,878,180 | 1.9 M to 1.9 M (-0.04 %) |
Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 31.08 | 10,320 | 320,746 | 1,878,980 | 1.9 M to 1.9 M (-0.55 %) |
Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 30.01 | 11,120 | 333,711 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
Oct 25 2019 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 20,000 | 6,600 | 780,000 | |
Oct 25 2019 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 20,000 | 6,600 | 1,878,180 | 1.9 M to 1.9 M (+1.08 %) |
Jul 03 2019 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | C | 0.00 | 70,680 | 0 | 0 | |
Jul 03 2019 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | C | 0.00 | 70,680 | 0 | 1,858,180 | 1.8 M to 1.9 M (+3.95 %) |